Vir Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEOMarianne de Backer
CEOMarianne de Backer
Employees408
Employees408
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2016
Founded2016
Employees408
Employees408
VIR Key Statistics
Market cap1.07B
Market cap1.07B
Price-Earnings ratio-2.13
Price-Earnings ratio-2.13
Dividend yield—
Dividend yield—
Average volume1.54M
Average volume1.54M
High today$7.72
High today$7.72
Low today$7.10
Low today$7.10
Open price$7.41
Open price$7.41
Volume1.59M
Volume1.59M
52 Week high$10.01
52 Week high$10.01
52 Week low$4.16
52 Week low$4.16
Stock Snapshot
The current Vir Biotechnology(VIR) stock price is $7.71, with a market capitalization of 1.07B. The stock trades at a price-to-earnings (P/E) ratio of -2.13.
On 2026-02-13, Vir Biotechnology(VIR) stock traded between a low of $7.10 and a high of $7.72. Shares are currently priced at $7.71, which is +8.6% above the low and -0.1% below the high.
Vir Biotechnology(VIR) shares are trading with a volume of 1.59M, against a daily average of 1.54M.
In the last year, Vir Biotechnology(VIR) shares hit a 52-week high of $10.01 and a 52-week low of $4.16.
In the last year, Vir Biotechnology(VIR) shares hit a 52-week high of $10.01 and a 52-week low of $4.16.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VIR. This list is generated using Robinhood data, and it’s not a recommendation.